FLT4 and neoplasm: VEGF-C is predominantly expressed along with VEGF receptor-3 (VEGFR-3), mainly in lymphatic capillaries, where it activates the development of tumor-associated lymphatic vessels and facilitates the access of tumor cells into these vessels (13–16).